^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    monalizumab (IPH2201)

    i
    Other names: IPH2201, NNC 0141-0000-0100, NN8765, IPH 2201, IPH22XX, NN8765-3658
    Associations
    News
    Trials
    Company:
    AstraZeneca, Innate
    Drug class:
    NKG2A inhibitor
    Related drugs:
    Associations
    News
    Trials